WILSON KAREN J — SEC Form 4 filings
SEC reporting owner CIK 1267490. 10 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-11-25 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 2 filings — 30,100 shares, $54,750 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 10,000 shares @ $1.93 ($19,300) in Serina Therapeutics, Inc., filed 2026-05-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Serina Therapeutics, Inc. (SER) | Director | 5 | 4 legs · 30,100 sh · $54,750 | — | 3 |
| Elicio Therapeutics, Inc. (ELTX) | Director | 3 | — | — | 3 |
| LAVA Therapeutics NV (LVTX) | Director | 2 | — | — | 3 |
Form 4 filings — WILSON KAREN J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 21,750 (derivative) @ $0 | EDGAR |
| 2026-06-22 | 4 | Serina Therapeutics, Inc. (SER) | Grant/award (A): 15,250 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | Serina Therapeutics, Inc. (SER) | Purchase (P): 5,100 @ $1.75 · Purchase (P): 5,000 @ $1.77 | EDGAR |
| 2026-05-26 | 4 | Serina Therapeutics, Inc. (SER) | Purchase (P): 10,000 @ $1.77 · Purchase (P): 10,000 @ $1.93 | EDGAR |
| 2025-11-17 | 4 | LAVA Therapeutics NV (LVTX) | Disposition to issuer (D): 10,000 · Disposition to issuer (D): 33,390 (derivative) @ $0 | EDGAR |
| 2025-11-10 | 4 | Serina Therapeutics, Inc. (SER) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2025-05-20 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 7,900 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | LAVA Therapeutics NV (LVTX) | Grant/award (A): 33,390 (derivative) @ $0 | EDGAR |
| 2025-01-15 | 4 | Serina Therapeutics, Inc. (SER) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Elicio Therapeutics, Inc. (ELTX) | Grant/award (A): 4,100 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1267490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →